Cargando…
Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
Alzheimer’s disease (AD) is a commonly occurring neurodegenerative disease in the advanced-age population, with a doubling of prevalence for each 5 years of age above 60 years. In the past two decades, there has been a sustained effort to find suitable biomarkers that may not only aide with the diag...
Autores principales: | Omar, Syed Haris, Preddy, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563364/ https://www.ncbi.nlm.nih.gov/pubmed/32708853 http://dx.doi.org/10.3390/jpm10030063 |
Ejemplares similares
-
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
por: Nguyen, Thuy Trang, et al.
Publicado: (2020) -
Advantages and pitfalls of clinical application of sugammadex
por: Lee, Hyung Young, et al.
Publicado: (2020) -
Patient-specific instruments: advantages and pitfalls
por: Hafez, Mahmoud A., et al.
Publicado: (2017) -
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018) -
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019)